-
Enterocyte-like differentiation defines metabolic gene signatures of CMS3 colorectal cancers and provides therapeutic vulnerability
Torang, A., Kirov, A. B., Lammers, V., Cameron, K., Wouters, V. M., Jackstadt, R. F., Lannagan, T. R. M., de Jong, J. H., Koster, J., Sansom, O. & Medema, J. P., 1 Dec 2025, In: Nature communications. 16, 1, 264.Research output: Contribution to journal › Article* › Academic › peer-review
-
GSK-3 and BCL-XL inhibition mitigates the competitive advantage of APC-mutant colorectal cancer cells
Zhang, L., Atencia Taboada, L., Baglamis, S., de Kroon, M., Elshout, C., Ramesh, P., Helderman, R. F. C. P. A., Torang, A., Cameron, K., van Driel, M. S., Wouters, V. M., van Neerven, S. M. & Medema, J. P., 1 Dec 2025, In: Oncogenesis. 14, 1, 25.Research output: Contribution to journal › Article* › Academic › peer-review
-
CDX2 downregulation regulates intrinsic WNT pathway activation, dictating metastasis in APC and CTNNB1 wildtype colorectal cancer
Wouters, V. M., Helderman, R. F. C. P. A., Cameron, K., van der Hooff, S. R., Torang, A., van den Bergh, S., Jackstadt, R., Sansom, O. J., van Neerven, S. M. & Medema, J. P., 7 Jul 2025, In: Oncogene. 44, 25, p. 2091-2102 12 p., 4443.Research output: Contribution to journal › Article* › Academic › peer-review
- All publications
